Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class ASSE: 603168

Announcement on Receipt of the "Letter of Shareholder Suggestions" from the China Securities Investor Services Center

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Receipt of the "Letter of Shareholder Suggestions" from the China Securities Investor Services Center

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis